Table 2 Presentation, treatment strategies, and outcomes of patients with endophthalmitis caused by Pseudomonas aeruginosa
No. | Baseline VA | Initial VA | Initial Tx | Initial IVTI | Additional Tx (Days after presentation) | Additional IVTI (Days after presentation) | Last VA | Follow-up time |
|---|---|---|---|---|---|---|---|---|
1 | UK | LP | T + I | Unknown | PPV (1) | Cfx (2) Ctz (3) | NLP | 2 years |
2 | UK | LP | PPV | Vanc + Ctz (intra-op) | Enucleation | – | Enucleation | 7 years |
3 | UK | UK | UK | UK | UK | UK | UK | UK |
4 | UK | HM | T + I | UK | Enucleation (6) | – | Enucleation | 8 months |
5 | UK | LP | T + I | Vanc + Ctz + Dex | PPV (4) | Vanc + Dex (4) Ctz (8) | CF | 3 months |
6 | UK | LP | T + I | Vanc + Ctz | PPV (4) | Ctz (2 & 8) Ctz intra-op (4) | LP | 2 days |
7 | UK | LP | T + I | Ctz + Vanc | – | Vanc + Dex (2) Vanc + Ctz + Dex (5) | LP | 4 years |
8 | UK | HM | Globe repair PPV | Vanc + Ctz + Vcz (intra-op) | Retinal detachment repair (4 months) | – | 20/400 | 2 years |